{
    "type": "ETP",
    "ucits": false,
    "replication_method": "physical",
    "leverage": true,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "complex_factors": [
        "Leverage",
        "Daily Compounding",
        "High Risk Profile"
    ],
    "classification": "complex",
    "supporting_data": "The product is a Collateralised Exchange Traded Security (ETP) that provides 2x daily leveraged exposure to Apple Inc. stock by physically owning the underlying shares and using margin (borrowing) to purchase additional shares. There is no use of synthetic replication or swap agreements. The replication method is physical, with direct ownership of Apple shares. However, the product employs leverage (2x) and daily rebalancing, which introduces complexity through compounding effects and amplified returns. The risk indicator is high (6 out of 7), reflecting the elevated risk and complexity. The product is not UCITS compliant. The KIID and factsheet emphasize the need for sophisticated investors who understand leverage, daily rebalancing, and compounding risks. There is no capital protection, and the product may result in losses exceeding expectations due to volatility and compounding. No derivative instruments are used inherently in the strategy, only margin borrowing. No swap or counterparty risk is identified. The complexity arises primarily from the leverage, daily compounding, and the sophisticated risk profile, making it difficult for retail investors to understand fully. The PRIIPs KID also includes a comprehension warning and highlights the product's complexity and risk. Therefore, under MiFID II, the product is classified as complex due to leverage and the nature of the product, despite physical replication and no derivative usage."
}